Sharon Cheetham

Biography

 Sharon manages our experimental services. Between 1997 and 2001, she was Section Leader in Obesity Research at BASF Pharma with responsibility for all CNS-based projects. While at BASF Pharma she assisted with the global registration of the antiobesity agent, sibutramine. Between 1993 and 1997, Sharon was responsible for research projects in the therapeutic areas of depression and Parkinson’s Disease at BASF Pharma/Boots Pharmaceuticals. Sharon holds a PhD in Neuropharmacology from the University of London and an MSc in Toxicology from the University of Birmingham and is a visiting lecturer at the University of Nottingham. Sharon has over 60 scientific publications.

Research Interest

 Neuropharmacology, Toxicology